The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients

Maja Smerdel; Karina Dahl Steffensen; Marianne Waldstrøm; Ivan Brandslund; Anders Jakobsen

The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients

Maja Smerdel, Karina Dahl Steffensen, Marianne Waldstrøm, Ivan Brandslund, Anders Jakobsen

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	2009
Publication status	Published - 2009
Event	International Meeting of the European Society of Gynaecological Oncology - Beograd, Serbia Duration: 11. Oct 2009 → 14. Oct 2009 Conference number: 16

Conference

Conference	International Meeting of the European Society of Gynaecological Oncology
Number	16
Country/Territory	Serbia
City	Beograd
Period	11/10/2009 → 14/10/2009

Bibliographical note

Citation: Journal of Gynecological Cancer, Volume 19, October 2009, Supplement 2
Oral presentation

Documents & Links

http://journals.lww.com/ijgc/Documents/ESGO%2016%20Abstracts,%20Belgrade,%20Serbia.pdf

Cite this

Smerdel, M., Dahl Steffensen, K., Waldstrøm, M., Brandslund, I., & Jakobsen, A. (2009). The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients. Abstract from International Meeting of the European Society of Gynaecological Oncology, Beograd, Serbia. http://journals.lww.com/ijgc/Documents/ESGO%2016%20Abstracts,%20Belgrade,%20Serbia.pdf

@conference{b016cf10158611dfb94c000ea68e967b,

title = "The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients",

author = "Maja Smerdel and {Dahl Steffensen}, Karina and Marianne Waldstr{\o}m and Ivan Brandslund and Anders Jakobsen",

note = "Citation: Journal of Gynecological Cancer, Volume 19, October 2009, Supplement 2 Oral presentation; null ; Conference date: 11-10-2009 Through 14-10-2009",

year = "2009",

language = "English",

}

Smerdel, M, Dahl Steffensen, K, Waldstrøm, M, Brandslund, I & Jakobsen, A 2009, 'The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients', International Meeting of the European Society of Gynaecological Oncology, Beograd, Serbia, 11/10/2009 - 14/10/2009. <http://journals.lww.com/ijgc/Documents/ESGO%2016%20Abstracts,%20Belgrade,%20Serbia.pdf>

The predictive value of serum VEGF/VEGFRI-2 in bevacizumab treated ovarian cancer patients. / Smerdel, Maja; Dahl Steffensen, Karina; Waldstrøm, Marianne; Brandslund, Ivan ; Jakobsen, Anders.

2009. Abstract from International Meeting of the European Society of Gynaecological Oncology, Beograd, Serbia.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review